Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

Hu, S L; Abrams, K; Barber, G N; Moran, P; Zarling, J M; Langlois, A J; Kuller, L; Morton, W R; Benveniste, R E

Hu, S L; Abrams, K; Barber, G N; Moran, P; Zarling, J M; Langlois, A J; Kuller, L; Morton, W R; Benveniste, R E.

Affiliation

Hu SL; Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

Science ; 255(5043): 456-9, 1992 Jan 24.

Article in En | MEDLINE | ID: mdl-1531159

Subject(s)

Simian Acquired Immunodeficiency Syndrome/prevention & control; Simian Immunodeficiency Virus/immunology; Vaccines, Synthetic/immunology; Viral Vaccines/immunology; Animals; Base Sequence; DNA, Viral/genetics; Gene Products, env; Genetic Vectors; Lymphocyte Activation; Macaca fascicularis; Molecular Sequence Data; Neutralization Tests; Oligonucleotides/chemistry; Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome/immunology; T-Lymphocytes, Helper-Inducer/immunology; Time Factors; Vaccination

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Viral Vaccines / Vaccines, Synthetic / Simian Acquired Immunodeficiency Syndrome / Simian Immunodeficiency Virus Limits: Animals Language: En Year: 1992 Type: Article

Search on Google

XML

PubMed Links